Risk of ipsilateral and contralateral cancer in BRCA mutation carriers with breast cancer

被引:3
|
作者
Green L. [1 ]
Meric-Bernstam F. [1 ]
机构
[1] Department of Surgical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030
关键词
BRCA1; BRCA2; Contralateral breast cancer; Prophylactic mastectomy;
D O I
10.1007/s12609-011-0047-3
中图分类号
学科分类号
摘要
BRCA1 and BRCA2 mutation carriers with breast cancer have a high risk of ipsilateral breast cancer tumor recurrence (IBTR) and a high lifetime risk of contralateral breast cancer (CBC). The IBTR risk is significantly higher in women who elect breast conservation. Oophorectomy has a protective effect for both ipsilateral breast tumor recurrence and CBC. Patients with younger age of breast cancer onset have a significantly greater risk of CBC. Given the higher risk of IBTR and CBC, when indicated, patients with breast cancer should undergo genetic counseling early in their treatment course to assist them in their surgical decision-making. Knowledge of expected outcomes for BRCA1/2 mutation carriers following breast cancer treatment can help in appropriately counseling patients and personalizing cancer therapy. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:151 / 155
页数:4
相关论文
共 50 条
  • [1] Therapeutic radiation for breast cancer in BRCA mutation carriers and contralateral breast cancer (CBC) risk
    Moore, H. C.
    Wesolowski, R.
    Choueiri, T. K.
    Rybicki, L.
    Shealy, A. G.
    Casey, G.
    Weng, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Aromatase inhibitors and the risk of contralateral breast cancer in BRCA mutation carriers.
    Shafaee, Maryam Nemati
    Gutierrez-Barrera, Angelica M.
    Lin, Heather Y.
    Arun, Banu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [3] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly Metcalfe
    Henry T. Lynch
    Parviz Ghadirian
    Nadine Tung
    Charmaine Kim-Sing
    Olufunmilayo I. Olopade
    Susan Domchek
    Andrea Eisen
    William D. Foulkes
    Barry Rosen
    Danny Vesprini
    Ping Sun
    Steven A. Narod
    [J]. Breast Cancer Research and Treatment, 2011, 127 : 287 - 296
  • [4] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, Kelly
    Lynch, Henry T.
    Ghadirian, Parviz
    Tung, Nadine
    Kim-Sing, Charmaine
    Olopade, Olufunmilayo I.
    Domchek, Susan
    Eisen, Andrea
    Foulkes, William D.
    Rosen, Barry
    Vesprini, Danny
    Sun, Ping
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 287 - 296
  • [5] Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Graeser, Monika K.
    Engel, Christoph
    Rhiem, Kerstin
    Gadzicki, Dorothea
    Bick, Ulrich
    Kast, Karin
    Froster, Ursula G.
    Schlehe, Bettina
    Bechtold, Astrid
    Arnold, Norbert
    Preisler-Adams, Sabine
    Nestle-Kraemling, Carolin
    Zaino, Mohammad
    Loeffler, Markus
    Kiechle, Marion
    Meindl, Alfons
    Varga, Dominic
    Schmutzler, Rita K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5887 - 5892
  • [6] Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
    Shafaee, Maryam Nemati
    Goutsouliak, Kristina
    Lin, Heather
    Bevers, Therese B.
    Gutierrez-Barrera, Angelica
    Bondy, Melissa
    Arun, Banu
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (01) : 143 - 152
  • [7] Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
    Maryam Nemati Shafaee
    Kristina Goutsouliak
    Heather Lin
    Therese B. Bevers
    Angelica Gutierrez-Barrera
    Melissa Bondy
    Banu Arun
    [J]. Breast Cancer Research and Treatment, 2022, 196 : 143 - 152
  • [8] Increased risk of contralateral breast cancer for BRCA1 mutation carriers compared to BRCA2 mutation carriers
    Graeser, M.
    Engel, C.
    Zaino, M.
    Schmutzler, R.
    [J]. ONKOLOGIE, 2008, 31 : 28 - 28
  • [9] Risk of contralateral breast cancer amongst BRCA1/2 mutation carriers
    Basu, Narendra Nath
    Evans, D. Gareth
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1066 - S1069
  • [10] Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Phillips, Kelly-Anne
    Milne, Roger L.
    Rookus, Matti A.
    Daly, Mary B.
    Antoniou, Antonis C.
    Peock, Susan
    Frost, Debra
    Easton, Douglas F.
    Ellis, Steve
    Friedlander, Michael L.
    Buys, Saundra S.
    Andrieu, Nadine
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Bonadona, Valerie
    Pujol, Pascal
    McLachlan, Sue Anne
    John, Esther M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    Tollenaar, Rob A. E. M.
    Goldgar, David E.
    Terry, Mary Beth
    Caldes, Trinidad
    Weideman, Prue C.
    Andrulis, Irene L.
    Singer, Christian F.
    Birch, Kate
    Simard, Jacques
    Southey, Melissa C.
    Olsson, Hakan L.
    Jakubowska, Anna
    Olah, Edith
    Gerdes, Anne-Marie
    Foretova, Lenka
    Hopper, John L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3091 - 3099